Obama: Cut The Red Tape..
- von: Dave Foggia (www.nasalinsert.com)
- empfänger: President Obama
In an unprecedented move, bird flu scientists in the Netherlands (funded by the U.S. Government) have caved to international scientific outcry and agreed to a self-imposed moratorium on their research for sixty days (from January 20, 2012) due to the fact that they have created a new version of the H5N1 bird flu virus able to go airborne. The human death rate of prior H5N1 flu viruses not able to go airborne is over 50%. If this new strain of the H5N1 were to enter the environment, the existing pandemic countermeasures in place by governments worldwide would certainly be inadequate to halt its spread. As was seen with the 2009 H1N1 (Swine Flu) virus, it too would rapidly spread around the world in an equally swift and uncontrollable manner. WHO and US. HHS officials have not offered anything new in the way of pandemic countermeasures that would significantly alter rapid global contamination. The global health and economic effects would be devastating.
In August of 2009, two Emergency Use Authorizations (EUAs) were filed with the U.S. FDA. These EUA(s) notified the U.S. Federal Government of a new nasal technology proposed as: 1.) a far safer, more efficient form of vaccine delivery that would tend to extend limited supplies of pandemic vaccine, and 2.) a pandemic countermeasure or pathogen filter with strong potential to safely reduce nasal colonization of pandemic viruses. These two EUA(s) were systematically buried in bureaucracy and red tape and the technology to this day continues to be systematically ignored by leading Gov. Health Officials.
The HHS Secretary has been assigned the task and funded with multi-billions of dollars to exhaust every conceivable option against the transmission of pandemic viruses, extend limited supplies of pandemic vaccines, and make all vaccines as safe as possible. Ask President Obama to issue an Executive Order mandating the immediate development, testing, distribution and stockpiling of this simple and inexpensive new technology. It could prove to reduce or even contain pandemic spread and deliver vaccines far more safely.
In relation to this, it has come to my attention that two Emergency Use Authorizations (EUAs) were filed with the FDA in August of 2009 pertaining to the H1N1 Pandemic. I understand that the first of these EUA(s) in effect informed the HHS of a new nasal technology with the potential to safely and effectively reduce nasal colonization and thus transmission of pandemic pathogens. The second EUA offered a way to use the same technology to provide a far safer, likely more efficient method of vaccine delivery which would also tend to extend limited supplies of pandemic vaccines. I have reviewed the information about this new technology and agree with the inventor that it clearly has direct implications and potential for these applications. The concept is fairly simple and straightforward, so I question the lack of interest and action on the part of the U.S. Health Secretary in this matter. I can see how the pharmaceutical industry would be against this inexpensive technology and method, but to allow their interference in this matter at the cost to me and my family is unacceptable.
[Your comments here..]
The HHS Pandemic Influenza Plan mandates that the Secretary is to exhaust every conceivable option toward preventing the transmission of pandemic influenza, and take all measures to extend limited supplies of pandemic vaccines. She is also charged with insuring that influenza vaccines are as safe and effective as possible. I fail to see how this new nasal technology is not directly in line with this Mandate.
I am therefore calling on you to issue an Executive Order if necessary granting full regulatory clearance to this technology and immediate HHS directed development, testing (NIH, NIAID), distribution and stockpiling (DHS, FEMA) in America as a viable pandemic countermeasure.
Sincerely,
[Your Signature]
Wenn Sie hier unterzeichnen, akzeptieren Sie die Nutzungsbedingungen von Care2
Sie können Ihre E-Mail-Abonnements jederzeit verwalten.
Sie haben Probleme, dies zu unterzeichnen? Informieren Sie uns.